Digital Health Late Stage Investors & VC Firms

183 firms in this list, with a median first check of $1.4M. 44 of them lead rounds. Generated from verified public data and updated continuously.

Fund	FoxScore	HQ	Invests	Stage	Check	CRM
FR Fresenius Medical Care Ventures AWAWASBH7 people	88🔒	Bad Homburg	DE	Seed–Late Stage	—	+ Add to CRM
DI Digital Horizon HHRMVTLR4 people · Leads rounds	88🔒	George Town	KY	Pre-Seed–Late Stage	—	+ Add to CRM
EV Evidity Health Capital ASPELSLA5 people	88🔒	New York	US	Growth–Late Stage	$5M	+ Add to CRM
RO Rosetta Capital Ltd. JHKMMFDL8 people	88🔒	Oxford	GB	Growth–Late Stage	—	+ Add to CRM
AV Avego BioScience Capital ARBV2 people · Leads rounds	88🔒	Alpharetta	US	Series A–Late Stage	—	+ Add to CRM
CL CLI Ventures ZLJSZPXC6 people	88🔒	Palo Alto	US	Seed–Late Stage	—	+ Add to CRM
SE Sectoral Asset Management FBGDMSMM8 people	88🔒	Montreal	CA	Series B–Late Stage	—	+ Add to CRM
AG Agate Medical Investments LP	88🔒	Tel-Aviv	IL	Growth–Late Stage	—	+ Add to CRM
WE West Capital MLMRABMM9 people	88🔒	Alpine	US	Series A–Late Stage	—	+ Add to CRM
CL Clal Biotechnology Industries AALNNMAF8 people	88🔒	Tel Aviv	IL	Seed–Late Stage	—	+ Add to CRM
WH What If Ventures SHJNRT3 people · Follows rounds	88🔒	Frisco	US	Pre-Seed–Late Stage	—	+ Add to CRM
CL Claremont Creek Ventures NGRHBWGO5 people	88🔒	Oakland	US	Seed–Late Stage	$500K – $3M	+ Add to CRM
VE Vesalius Biocapital III Partners SàRL CSGGMLSV11 people	88🔒	Contern	LU	Series B–Late Stage	$10.8M	+ Add to CRM
EL Elysium Ventures NOPXELDC5 people	88🔒	Sunnyvale	US	Seed–Late Stage	—	+ Add to CRM
NA naturalX Health Ventures MACPSBYC4 people · Leads rounds	88🔒	Karlsruhe	DE	Seed–Late Stage	$3.2M – $5.4M	+ Add to CRM
QU Quest for Growth SLAPBDHF8 people	88🔒	Leuven	BE	Growth–Late Stage	—	+ Add to CRM
KA Kamino Digital Assets KCMLRM3 people	88🔒	—		Seed–Late Stage	—	+ Add to CRM
HE Healthcare Venture Partners, Llc MYJDASGG8 people	88🔒	Charleston	US	Growth–Late Stage	—	+ Add to CRM
MA Mayo Clinic Ventures AJPA2 people	88🔒	Rochester	US	Seed–Late Stage	—	+ Add to CRM
PI Ping An Japan Investment NTCCKTTK9 people	88🔒	Tokyo	JP	Growth–Late Stage	—	+ Add to CRM
FL Flintera SVNDRUAC4 people · Leads rounds	88🔒	—		Growth–Late Stage	$10M – $60M	+ Add to CRM
AX Axil Capital FSHGASJP7 people	88🔒	Tokyo	JP	Seed–Late Stage	—	+ Add to CRM
OS OSK Ventures International	88🔒	Kuala Lumpur	MY	Growth–Late Stage	—	+ Add to CRM
FL Fletcher Spaght, Inc. PSBGBSLG8 people	88🔒	Boston	US	Late Stage	—	+ Add to CRM

Fresenius Medical Care Ventures

Bad HomburgSeed–Late Stage

AWAWASBH7 people

Digital Horizon

George TownPre-Seed–Late Stage

HHRMVTLR4 people

Evidity Health Capital

New YorkGrowth–Late Stage$5M

ASPELSLA5 people

Rosetta Capital Ltd.

OxfordGrowth–Late Stage

JHKMMFDL8 people

Avego BioScience Capital

AlpharettaSeries A–Late Stage

ARBV2 people

CLI Ventures

Palo AltoSeed–Late Stage

ZLJSZPXC6 people

Sectoral Asset Management

MontrealSeries B–Late Stage

FBGDMSMM8 people

Agate Medical Investments LP

Tel-AvivGrowth–Late Stage

West Capital

AlpineSeries A–Late Stage

MLMRABMM9 people

Clal Biotechnology Industries

Tel AvivSeed–Late Stage

AALNNMAF8 people

What If Ventures

FriscoPre-Seed–Late Stage

SHJNRT3 people

Claremont Creek Ventures

OaklandSeed–Late Stage$500K – $3M

NGRHBWGO5 people

Vesalius Biocapital III Partners SàRL

ConternSeries B–Late Stage$10.8M

CSGGMLSV11 people

Elysium Ventures

SunnyvaleSeed–Late Stage

NOPXELDC5 people

naturalX Health Ventures

KarlsruheSeed–Late Stage$3.2M – $5.4M

MACPSBYC4 people

Quest for Growth

LeuvenGrowth–Late Stage

SLAPBDHF8 people

Kamino Digital Assets

Seed–Late Stage

KCMLRM3 people

Healthcare Venture Partners, Llc

CharlestonGrowth–Late Stage

MYJDASGG8 people

Mayo Clinic Ventures

RochesterSeed–Late Stage

AJPA2 people

Ping An Japan Investment

TokyoGrowth–Late Stage

NTCCKTTK9 people

Flintera

Growth–Late Stage$10M – $60M

SVNDRUAC4 people

Axil Capital

TokyoSeed–Late Stage

FSHGASJP7 people

OSK Ventures International

Kuala LumpurGrowth–Late Stage

Fletcher Spaght, Inc.

BostonLate Stage

PSBGBSLG8 people

Data sourced from public filings and firms' own websites — see our methodology.